Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-6-carboxylate, 95.0%, 250mg

Rel-(1R,2R)-2-((benzyloxy)carbonyl)cyclopropane-1-carboxylic acid, 98.0%, 1g

2-Chloro-3-ethynylpyridine, 97%, 1g

4-Bromo-6-(methylthio)pyrimidine, 95.0%, 1g

3-METHYL-6-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE, 95%, 250mg

1,2-Heptanediol>98.0%(GC)5g

1-(4-{3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy}-3-methoxyphenyl)ethan-1-one, 97.0%, 250mg

1-(4-Bromo-phenyl)-3-dimethylamino-propenone, 97.0%, 1g

(R)-3-(2-Chloro-acetylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid, 97%, 25mg

Vigreux column without shell, 300 mm, 29/32, 1 Piece

Naphthalene-1,4-dicarboxaldehyde, 98%, 10g

(2R,3R)-1-(tert-Butoxycarbonyl)-3-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 1g